Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist
- PMID: 34695770
- DOI: 10.1016/j.ttbdis.2021.101854
Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist
Abstract
Our objective was to study the consumption of healthcare services and antibiotics in patients with suspicion of disseminated Lyme borreliosis (LB) before and after consultation of an infectious disease specialist. We evaluated retrospectively all presumed disseminated LB patients (n = 256) with a referral to the Department of Infectious Diseases (DID) in Helsinki University Hospital in 2013. Medical records from all healthcare providers in the area were reviewed and the number of physician contacts because of symptoms leading to LB suspicion and antimicrobial purchases were calculated 1 year before and after consultation or treatment at the DID. Patients were divided into three groups according to certainty of LB: unlikely, possible or probable/definite LB. The number of healthcare contacts 1 year before referral was higher among 121 patients with unlikely LB (6; interquartile range [IQR] 3-10), than 65 possible (4; IQR 2.5-7; p = 0.018) or 66 probable/definite LB patients (4; IQR 2.8-7; p = 0.010). The median number of contacts to healthcare during one year after consultation or treatment was 3 (IQR 0.5-7), 1 (IQR 0-3) and 0.5 (IQR 0-2.3), respectively, with a statistically significant difference between the groups (p<0.001). Antibiotics were purchased by 151 (60%) patients one year before referral and by 127 (50%) patients year after consultation or treatment at DID without statistically significant difference between groups with different LB certainty. These antibiotic purchases do not include the treatments prescribed by infectious disease specialists. In the case of 27 patients, an antimicrobial treatment was recommended in the consultation reply. In conclusion, patients with unlikely LB used more healthcare services than patients with possible or probable/definite LB. Antimicrobial consumption was similar between groups of different LB certainty.
Keywords: Antibiotics; Borrelia burgdorferi sensu lato; Consumption of healthcare services; Finland; Healthcare; Lyme borreliosis.
Copyright © 2021. Published by Elsevier GmbH.
Similar articles
-
Suspicion of Lyme borreliosis in patients referred to an infectious diseases clinic: what did the patients really have?Clin Microbiol Infect. 2021 Jul;27(7):1022-1028. doi: 10.1016/j.cmi.2020.09.022. Epub 2020 Sep 23. Clin Microbiol Infect. 2021. PMID: 32979573
-
Is there Lyme borreliosis in French Guiana? Descriptive study among patients referred for a suspected Lyme borreliosis in an Amazonian hospital between 2010 and 2022.Ticks Tick Borne Dis. 2024 Jan;15(1):102255. doi: 10.1016/j.ttbdis.2023.102255. Epub 2023 Sep 20. Ticks Tick Borne Dis. 2024. PMID: 37734165
-
Lyme borreliosis in Finland: a register-based linkage study.BMC Infect Dis. 2020 Nov 10;20(1):819. doi: 10.1186/s12879-020-05555-w. BMC Infect Dis. 2020. PMID: 33167874 Free PMC article.
-
Borreliosis: recent research, diagnosis, and management.Scand J Rheumatol. 2008 May-Jun;37(3):161-72. doi: 10.1080/03009740801978897. Scand J Rheumatol. 2008. PMID: 18465449 Review.
-
Dermatological manifestations of Lyme borreliosis.Eur J Dermatol. 2004 Sep-Oct;14(5):296-309. Eur J Dermatol. 2004. PMID: 15358567 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical